Newron Pharmaceuticals S.p.A. (0QOI.L)

CHF 8.22

(0.24%)

EBITDA Summary of Newron Pharmaceuticals S.p.A.

  • Newron Pharmaceuticals S.p.A.'s latest annual EBITDA in 2023 was -11.83 Million EUR , up 10.81% from previous year.
  • Newron Pharmaceuticals S.p.A.'s latest quarterly EBITDA in 2024 Q2 was -7.58 Million EUR , down 0.0% from previous quarter.
  • Newron Pharmaceuticals S.p.A. reported an annual EBITDA of -13.32 Million EUR in 2022, down -7.76% from previous year.
  • Newron Pharmaceuticals S.p.A. reported an annual EBITDA of -12.31 Million EUR in 2021, up 31.59% from previous year.
  • Newron Pharmaceuticals S.p.A. reported a quarterly EBITDA of -4.2 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Newron Pharmaceuticals S.p.A. reported a quarterly EBITDA of N/A for 2023 FY, up 10.81% from previous quarter.

Annual EBITDA Chart of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Historical Annual EBITDA of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Year EBITDA EBITDA Growth
2023 -11.83 Million EUR 10.81%
2022 -13.32 Million EUR -7.76%
2021 -12.31 Million EUR 31.59%
2020 -17.99 Million EUR 13.69%
2019 -20.84 Million EUR -40.99%
2018 -14.78 Million EUR -265.27%
2017 -4.04 Million EUR 73.53%
2016 -15.29 Million EUR 13.13%
2015 -17.6 Million EUR -94.37%
2014 -11.18 Million EUR -17.06%
2013 -7.73 Million EUR -219.98%
2012 -2.63 Million EUR 61.81%
2011 -6.34 Million EUR 70.54%
2010 -21.49 Million EUR 10.57%
2009 -24.03 Million EUR -33.16%
2008 -18.04 Million EUR -33.31%
2007 -13.46 Million EUR 19.19%
2006 -16.72 Million EUR -11.12%
2005 -15.07 Million EUR 0.0%

Peer EBITDA Comparison of Newron Pharmaceuticals S.p.A.

Name EBITDA EBITDA Difference
Relief Therapeutics Holding AG -108.2 Million CHF 89.066%
Tecan Group AG 205.57 Million CHF 105.755%
Santhera Pharmaceuticals Holding AG 79.17 Million CHF 114.943%
Basilea Pharmaceutica AG 29.49 Million CHF 140.112%
Bachem Holding AG 163.27 Million CHF 107.246%
Siegfried Holding AG 241.21 Million CHF 104.905%
Molecular Partners AG -59.51 Million CHF 80.121%